Works matching IS 03682811 AND DT 2017 AND VI 47 AND IP 6


Results: 17
    1
    2
    3
    4
    5
    6

    Efficacy and safety of sequential use of everolimus in Japanese patients with advanced renal cell carcinoma after failure of first-line treatment with vascular endothelial growth factor receptor tyrosine kinase inhibitor: a multicenter phase II clinical trial

    Published in:
    Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 551, doi. 10.1093/jjco/hyw194
    By:
    • Masafumi Oyama;
    • Takayuki Sugiyama;
    • Masahiro Nozawa;
    • Kiyohide Fujimoto;
    • Takeshi Kishida;
    • Go Kimura;
    • Noriaki Tokuda;
    • Shiro Hinotsu;
    • Kojiro Shimozuma;
    • Hideyuki Akaza;
    • Seiichiro Ozono
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Comparison between neoadjuvant chemotherapy followed by surgery and definitive chemoradiotherapy for overall survival in patients with clinical Stage II/III esophageal squamous cell carcinoma (JCOG1406-A).

    Published in:
    Japanese Journal of Clinical Oncology, 2017, v. 47, n. 6, p. 480, doi. 10.1093/jjco/hyx040
    By:
    • Motoo Nomura;
    • Ken Kato;
    • Nobutoshi Ando;
    • Atsushi Ohtsu;
    • Kei Muro;
    • Hiroyasu Igaki;
    • Tetsuya Abe;
    • Hiroya Takeuchi;
    • Hiroyuki Daiko;
    • Masahiro Gotoh;
    • Kozo Kataoka;
    • Masashi Wakabayashi;
    • Yuko Kitagawa
    Publication type:
    Article
    17